statistiche ricercatore

Continente	#
NA - Nord America	371
AS - Asia	221
EU - Europa	133
SA - Sud America	43
Continente sconosciuto - Info sul continente non disponibili	16
AF - Africa	7
Totale	791

Nazione	#
US - Stati Uniti d'America	345
SG - Singapore	88
IT - Italia	52
HK - Hong Kong	35
CN - Cina	31
BR - Brasile	30
RU - Federazione Russa	26
VN - Vietnam	17
BD - Bangladesh	16
DE - Germania	15
CA - Canada	12
KR - Corea	12
FR - Francia	9
GB - Regno Unito	6
MX - Messico	5
AR - Argentina	4
IE - Irlanda	4
SE - Svezia	4
AT - Austria	3
FI - Finlandia	3
IL - Israele	3
IQ - Iraq	3
JP - Giappone	3
PL - Polonia	3
CO - Colombia	2
CW - ???statistics.table.value.countryCode.CW???	2
GT - Guatemala	2
ID - Indonesia	2
IN - India	2
NL - Olanda	2
SC - Seychelles	2
TR - Turchia	2
UZ - Uzbekistan	2
VE - Venezuela	2
AL - Albania	1
AZ - Azerbaigian	1
BB - Barbados	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
GE - Georgia	1
GY - Guiana	1
HN - Honduras	1
HT - Haiti	1
JM - Giamaica	1
LU - Lussemburgo	1
MA - Marocco	1
MD - Moldavia	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PR - Porto Rico	1
PT - Portogallo	1
PY - Paraguay	1
RE - Reunion	1
SA - Arabia Saudita	1
SD - Sudan	1
SK - Slovacchia (Repubblica Slovacca)	1
UA - Ucraina	1
UY - Uruguay	1
ZA - Sudafrica	1
Totale	777

Nome	#
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers	112
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP	94
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay	93
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum	89
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts	82
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease	79
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment	78
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function	68
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions	67
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease	29
Totale	791

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	5	0	0	0	0	0	0	0	3	0	0	1	1
2022/2023	28	1	5	0	2	5	1	0	2	9	0	3	0
2023/2024	54	0	0	3	3	1	0	5	5	18	5	3	11
2024/2025	123	1	12	2	7	8	11	8	15	23	6	18	12
2025/2026	398	20	34	14	68	51	27	58	16	32	40	25	13
2026/2027	178	12	17	61	73	15	0	0	0	0	0	0	0
Totale													791

IRIS - Res&Arch Institutional Research Information System - Research & Archive